West Pharmaceutical Services, Inc. (WST) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $340.62 -0.59%
Revenue Growth %: +2.5%
Financial Fact:
Equity in net income of affiliated companies: 2.7M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Revenue Growth %: +2.5%
Financial Fact:
Equity in net income of affiliated companies: 2.7M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q1 EPS of $0.38, $0.03 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $346.8 million versus the consensus estimate of $340.9 million.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ciena beats estimates on strong AI-driven demand, shares rise
- Dycom Industries (DY) PT Lowered to $375 at Raymond James
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
